Updated 5-year results for short course abiraterone acetate and LHRH agonist for unfavorable intermediate and favorable high-risk prostate cancer
Ryan E. Fecteau, Bridget F. Koontz, Karen E. Hoffman, Susan Halabi, Lauren E. Howard, Monika Anand, Daniel J. George, Tian Zhang, William R. Berry, W. Robert Lee, Michael R. Harrison, Paul G. Corn, Andrew J. Armstrong
Dive into the research topics of 'Updated 5-year results for short course abiraterone acetate and LHRH agonist for unfavorable intermediate and favorable high-risk prostate cancer'. Together they form a unique fingerprint.